J&J Pause Could Have Been More Targeted: Johns Hopkins’ Adalja
Dr. Amesh Adalja, Johns Hopkins Center for Health Security senior scholar, discusses the pause in the rollout of Johnson & Johnson’s Covid-19 vaccine on “Quicktake Charge.” The Johns Hopkins Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder of Bloomberg LP and Bloomberg Philanthropies. (Source: Bloomberg)